Veracyte Announces Second Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/16/2026
- Wall St futures mixed as tech wobbles again, Tesla gains
- Oil heads for weekly gain with focus on Middle East supply
- U.S. producer prices rise by 1.3% month-on-month in September
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
- Vertiv shares fall on analyst downgrades and options bets
- European stocks rise, dollar set for weekly loss after yields drop
- S&P 500 ends higher as traders shift from AI to healthcare
- Rocket Lab USA (RKLB) Reiterated at Overweight by Cantor Fitzgerald as Neutron Launch Moved to Next Year
- Caterpillar names Derrick York to lead Resource Industries
Veracyte, Inc (VCYT) PT Raised to $55 at Needham & Company
July 30, 2021 6:28 AM EDTNeedham & Company analyst Mike Matson raised the price target on Veracyte, Inc (NASDAQ: VCYT) to $55.00 (from $54.00) while maintaining a Buy rating.
The analyst commented, "VCYT's 2Q21 revenue and EPS beat consensus. Organic revenue growth improved to 77% in 2Q21 from 5.7% in 1Q21 as... More
Veracyte (VCYT) Tops Q2 EPS by 12c
July 29, 2021 4:26 PM EDTVeracyte (NASDAQ: VCYT) reported Q2 EPS of ($0.13), $0.12 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $55.1 million versus the consensus estimate of $48.06 million.
GUIDANCE:
Veracyte sees FY2021 revenue of $200-208 million, versus the consensus of $197.9... More



